Page last updated: 2024-08-24

tenofovir and Secondary Hyperparathyroidism

tenofovir has been researched along with Secondary Hyperparathyroidism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, L; Ma, W; Wei, D; Ye, P; Zeng, J1
Heldwein, S; Jaeger, H; Noe, S; Oldenbuettel, C; Pascucci, R; Ruecker, K; von Krosigk, A; Wiese, C; Wolf, E1

Reviews

1 review(s) available for tenofovir and Secondary Hyperparathyroidism

ArticleYear
Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adenine; Bone Diseases, Metabolic; Calcium; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Osteoporosis; Tenofovir

2022

Other Studies

1 other study(ies) available for tenofovir and Secondary Hyperparathyroidism

ArticleYear
Secondary Hyperparathyroidism in HIV-Infected Patients in Central Europe.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2018, Volume: 50, Issue:4

    Topics: Adult; Anti-Retroviral Agents; Calcium; Cross-Sectional Studies; Europe; Female; HIV; HIV Infections; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Tenofovir; Vitamin D

2018